Has Marjorie Tucker, NP received payments from drug or device companies?

Yes. Drug and device makers reported $2,589 in general payments to Marjorie Tucker, NP across 124 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marjorie Tucker, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marjorie Tucker, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marjorie Tucker, NP

Family · Longview, TXNPI 1538875729

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 26.6% of the total. 2025 is the largest year on record at $1,300, more than ten times the $125 reported in 2023.

$2,589in general payments, 2019–2025

Across 124 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$688
Lilly USA, LLC$343
Corcept Therapeutics$239
Novo Nordisk$230
Axsome Therapeutics, Inc.$158
Novartis$123
plus $807 from 18 others

What the payments were for

Food & beverage$2,589100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	32	$688
Lilly USA, LLC	17	$343
Corcept Therapeutics	7	$239
Novo Nordisk	13	$230
Axsome Therapeutics, Inc.	5	$158
Novartis	6	$123
Merck	7	$116
AstraZeneca	6	$101
Teva Pharmaceuticals USA, Inc.	3	$65
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$64
Lundbeck LLC	3	$64
GSK	4	$60
Bayer	3	$49
Phathom Pharmaceuticals, Inc.	2	$37
Exact Sciences	2	$37
Sumitomo Pharma America, Inc.	2	$35
Pfizer	2	$34
Amgen	2	$28
Vanda Pharmaceuticals Inc.	1	$24
Dynavax Technologies Corporation	1	$21
Otsuka America Pharmaceutical, Inc.	1	$21
Mayne Pharma Commercial LLC	1	$18
Kowa Pharmaceuticals America, Inc.	1	$17
Boehringer Ingelheim	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,589 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Medicare billing

Part B allowed, 2024

$38,980

Medicare patients

221

Services billed

1,305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	15	$2,741
Albuterol Sulfate HfaAlbuterol Sulfate	35	$602
Fluticasone Propionate	38	$529
Gabapentin	43	$508
Tizanidine Hcl	43	$361
Tramadol Hcl	34	$356
Levothyroxine Sodium	16	$269
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	22	$225
Methylprednisolone	34	$200
Lisinopril	28	$194
Cyclobenzaprine Hcl	16	$170
Triamcinolone Acetonide	16	$156
Methocarbamol	15	$144
Ibuprofen	16	$118
Amlodipine Besylate	12	$117

Paid to pharmacies, not to this prescriber.

Other family in Longview

David WeirDallas$959K
Robin BeachHouston$428K
April LopezMcAllen$417K
Sarah AguilarHouston$199K
Sie ThomasDallas$197K
Anna CastroSan Antonio$184K
Jill CampbellShenandoah$182K
Angela AchaPflugerville$174K
Susan BowlinIrving$164K
Stephanie RodriguezCorpus Christi$159K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →